EXACT Sciences Stock Price (NASDAQ:EXAS)

Add to My Stocks
$21.08 $0.59 (2.88%) EXAS stock closing price Mar 24, 2017 (Closing)
EXACT Sciences
24 MAR 2017
amigobulls logo
EXAS hand_up
EXAS vs S&P 500
Closing Price: Mar 24, 2017
$21.08 ( 2.88%)
S&P 500
2344 ( -0.08%)
52 Week Price Range
1 Year Return: 232.63%
Q4 Growth*
Profitable ?
net image
2016 Q4 Net Loss
home image
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen

EXACT Sciences Snapshot Video

14 5 2

EXAS Stock Details

Prev Close* : $20.49
Market Cap:
Day Low: $20.32
52 Week Low: $5.36
Open: $20.44
Volume: 2310510
Day High: $21.33
52 Week High: $24.50

Latest Stock Market News

Latest Articles

EXACT Sciences News - From Partners

EXAS Stockcharts

View EXAS PE ratio, PS ratio stocks charts and compare with peers.
EXAS Chart
Note: Compare EXACT Sciences stock price history with the index and industry peers.

EXACT Sciences Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

EXACT Sciences Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

EXAS Industry Peers

Company Price Change (%)
Horizon Pharma (HZNP)14.370.19 (1.3%)
Juno Therapeutics (JUNO)20.20.08 (0.39%)
Quest Diagnostics (DGX)98.70.43 (0.44%)
Transgenomic (TBIO)0.570 (0%)
Cancer Genetics (CGIX)3.90.55 (16.42%)
Invitae Corp (NVTA)10.40.19 (1.79%)
Ironwood Pharma (IRWD)17.140.01 (0.06%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

EXACT Sciences Corporation Stock News - Partner Headlines

EXACT Sciences Financial Statements

income statement20162015201420132012
Net Sales Or Revenues99.37M39.43M1.79M4.14M4.14M
Net Income-167.21M-157.8M-100.04M-46.51M-52.42M
Total Operating Expense223.19M174M98M50.89M56.78M
view EXACT Sciences Corporation income statement
balance sheet20162015201420132012
Total Assets377.04M364.29M311.62M146.62M112.11M
Total Liabilities41.74M37.44M22.64M11.31M13.52M
Shareholders Equity335.29M326.85M288.98M135.31M98.59M
view EXACT Sciences Corporation balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities1.76M-1.29M3.79M-1.19M4.24M
Net Cash From (Used By) Operating Activities-130.06M-134.01M-80.91M-39.29M-44.15M
Increase (Decrease) In Prop Plant And Equipment-14.85M-20.08M-12.53M-9.28M-0.68M
view EXACT Sciences Corporation cashflow statement

EXACT Sciences Stock Message Board

An investor needs to spend 21.08 to buy EXAS stock, as the closing EXACT Sciences stock price is 21.08. Stock price or share price can be used to find the total market value of a company. EXACT Sciences market cap stands at 2.27B as of 24 Mar, 2017. A value investor must look at the fundamentals of a stock, and perform EXACT Sciences valuation, even though in the short-term sentiment and current breaking news might affect EXACT Sciences stock price.

For recognizing and analyzing the real performance of EXACT Sciences stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. The volume of shares traded stood at 2310510 on the last trading day, as is evident from EXACT Sciences stock chart, and EXAS stock quote data. To check the historical stock price movement, all time high, and all time low of EXAS, view EXACT Sciences stock price history.